Tenderwize
Back to tender search

Open-house rebate agreements for sevelamer hydrochloride

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Nov 30, 2027 · 375 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Sevelamer hydrochlorid, ATC V03AE02

55/100

Opportunity Score

Needs reviewHigh complexity
SuppliesOpen
Why this score?

Opportunity

55 / 100

Complexity

67 / 100

Risk factors

The notice provides no value, volumes, demand forecast or guaranteed purchasing commitment.

The buyer may introduce exclusive discount agreements during the term, causing automatic termination of the open-house...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Country
Germany
CPV
33600000 - Pharmaceutical products
Deadline
Nov 30, 2027

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Jan 2028
  • Conclusion of non-exclusive pharmaceutical discount agreements under sections 130a(8) and 130c(1) SGB V.
  • Supply or inclusion of medicines containing the active substance sevelamer hydrochloride, ATC V03AE02.
Show full summary

Open-house model for non-exclusive pharmaceutical discount agreements concerning sevelamer hydrochloride (ATC V03AE02) offered by AOK Rheinland-Pfalz/Saarland. All interested pharmaceutical companies may join without a selection decision, subject to uniform non-negotiable conditions and proof that the medicines are authorised and marketable in Germany. Contracts may be concluded monthly during the 24-month period, but may end automatically if exclusive agreements replace them. No contract value is disclosed.

Risks

The notice provides no value, volumes, demand forecast or guaranteed purchasing commitment.

The buyer may introduce exclusive discount agreements during the term, causing automatic termination of the open-house...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • The participant must be a pharmaceutical company.
  • Medicines must be authorised and marketable in Germany.
  • Medicines included on the BfArM list under section 35(5a) SGB V for children's medicines are excluded.

Buyer

Lots (1)

LOT-0001

Open-house discount agreements for sevelamer hydrochloride

Non-exclusive discount agreements for medicines containing sevelamer hydrochloride, ATC V03AE02. The open-house model accepts all interested pharmaceutical companies meeting the stated requirements, with no individual negotiation. Medicines listed on the BfArM list under section 35(5a) SGB V for children's medicines are excluded. Lot information is derived from structured tender data and the extracted TED XML notice.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

Jan 2026 - Jan 2028

Category

Pharmaceutical products

Deadline

Deadline Nov 30, 2027

Procurement Details

Publication date
09 Dec 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
817811-2025

Documents (1)

Similar tenders

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy